000 | 01075 a2200301 4500 | ||
---|---|---|---|
005 | 20250515051201.0 | ||
264 | 0 | _c20070108 | |
008 | 200701s 0 0 eng d | ||
022 | _a1744-7658 | ||
024 | 7 |
_a10.1517/13543784.16.1.11 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCitterio, Paola | |
245 | 0 | 0 |
_aNovel inhibitors of the early steps of the HIV-1 life cycle. _h[electronic resource] |
260 |
_bExpert opinion on investigational drugs _cJan 2007 |
||
300 |
_a11-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xchemistry |
650 | 0 | 4 | _aCCR5 Receptor Antagonists |
650 | 0 | 4 |
_aDrugs, Investigational _xchemistry |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReceptors, CCR5 _xphysiology |
700 | 1 | _aRusconi, Stefano | |
773 | 0 |
_tExpert opinion on investigational drugs _gvol. 16 _gno. 1 _gp. 11-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.16.1.11 _zAvailable from publisher's website |
999 |
_c16724897 _d16724897 |